CBLN1 and Fabry disease: SM (d34:1), Cer (d18:0/16:0) and several glycosphingolipids including CerG3 (d18:1/14:0), CerG3 (d18:2/16:0), CerG3 (d18:1/16:0+O), CerG3 (d18:1/16:0), CerG3 (d18:1/24:1), CerG3GNAc1 (d36:2), CerG2 (d18:1/16:0+O) as well as CerG2GNAc1 (d32:1) were increased in Fabry disease compared with control, while CerG2GNAc1 (d41:4) decreased (Figure 2).